Coherent (COHR) announces the launch of new pin-hole array biochips for medical diagnostics, with a focus on gene sequencing applications. The company said, “Developed by the Coherent advanced optics team, this groundbreaking approach consolidates the entire production process, addressing key challenges in cost, efficiency, and supply chain management for professionals in the diagnostic field. Pin-hole array biochips from Coherent are available in a variety of formats, from bare wafers to fully assembled modules, providing unparalleled flexibility for diverse customer applications.”
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COHR:
- Investor Stanley Druckenmiller Says “Animal Spirits” are Back and to Buy AI Stocks
- Coherent announces availability of Ultrabroadband Diffraction Gratings
- Coherent price target raised to $125 from $105 at Barclays
- Coherent call volume above normal and directionally bullish
- Coherent put volume heavy and directionally bearish